Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Provention Bio, Inc. PRVB

Set alert

Price alert · PRVB

All alert types
24.98 0.00 0.00%

At close · Apr 26

24.98 Day range 25.00

52-week range unavailable

Open
24.99
Prev close
24.98
Mkt cap
2.38B
Vol
9.12M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
24.98
High
25.00
Forward P/E
-192.15
Beta
2.46
Short ratio
1.53
Inst. own
53.26%
Dividend
0.00
Ex-div date
Earnings
May 4, 2023
50-d avg
19.10
200-d avg
10.15
1y target
23.50

1Y chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • May 5, 2022Earnings: —; estimate -0.45; surprise —%
  • Aug 4, 2022Earnings: —; estimate -0.49; surprise —%
  • Nov 3, 2022Earnings: —; estimate -0.46; surprise —%
  • Nov 21, 2022Rating: SVB Leerink · — → Outperform
  • Feb 15, 2023Rating: HC Wainwright & Co. · — → Buy
  • Mar 13, 2023Rating: Chardan Capital · — → Buy
  • Mar 14, 2023Downgrade: Jefferies · Buy → Hold
  • Mar 14, 2023Downgrade: SMBC Nikko · Outperform → Neutral
  • Mar 15, 2023Downgrade: HC Wainwright & Co. · Buy → Neutral
Signals (53)
NameDateAgo
MACD: Sell SignalMar 31, 20233 years ago
SMA: BullishMar 13, 20233 years ago
MACD: Buy SignalMar 13, 20233 years ago
RSI: OverboughtMar 13, 20233 years ago
RSI: OversoldMar 10, 20233 years ago
RSI: OversoldMar 8, 20233 years ago
MACD: Sell SignalFeb 22, 20233 years ago
SMA: BearishFeb 21, 20233 years ago
SMA: BullishFeb 9, 20233 years ago
SMA: BearishFeb 8, 20233 years ago
SMA: BullishFeb 7, 20233 years ago
SMA: BearishFeb 6, 20233 years ago
MACD: Buy SignalFeb 6, 20233 years ago
SMA: BullishFeb 3, 20233 years ago
SMA: BearishJan 18, 20233 years ago
MACD: Sell SignalJan 18, 20233 years ago
MACD: Buy SignalJan 17, 20233 years ago
SMA: BullishJan 10, 20233 years ago
SMA: BearishJan 9, 20233 years ago
MACD: Sell SignalJan 4, 20233 years ago

Newest 20 of 53.

Financial health

Altman Z-Score

8.72 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -7.0×
FY 2016: 0.0×FY 2017: -17.8×FY 2018: -1.5×FY 2019: -14.3×FY 2020: -9.0×FY 2021: -3.1×FY 2022: -7.0×
FY 2016 5y median -7.0× FY 2022
P/S 61.3×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 254×FY 2022: 61.3×
FY 2016 5y median 0.0× FY 2022
P/B 6.5×
FY 2016: 0.0×FY 2017: 8.1×FY 2018: 0.7×FY 2019: -7.7×FY 2020: -5.0×FY 2021: -1.2×FY 2022: 6.5×
FY 2016 5y median -1.2× FY 2022
P/FCF -10.4×
FY 2016: 0.0×FY 2017: -33.4×FY 2018: -1.8×FY 2019: -16.8×FY 2020: -11.5×FY 2021: -3.7×FY 2022: -10.4×
FY 2016 5y median -10.4× FY 2022
EV/EBITDA -6.2×
FY 2016: 0.0×FY 2017: -15.5×FY 2018: 0.7×FY 2019: -12.8×FY 2020: -7.9×FY 2021: -2.4×FY 2022: -6.2×
FY 2016 5y median -6.2× FY 2022
EV/Sales 59.7×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 199×FY 2022: 59.7×
FY 2016 5y median 0.0× FY 2022
FCF Yield -9.6%
FY 2016: 0.0%FY 2017: -3.0%FY 2018: -57.0%FY 2019: -5.9%FY 2020: -8.7%FY 2021: -27.2%FY 2022: -9.6%
FY 2016 5y median -9.6% FY 2022

Profitability

Gross Margin 96.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 100.0%FY 2022: 96.0%
FY 2016 5y median 0.0% FY 2022
Operating Margin -993.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -8285.2%FY 2022: -993.9%
FY 2016 5y median 0.0% FY 2022
Net Margin -880.7%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -8203.0%FY 2022: -880.7%
FY 2016 5y median 0.0% FY 2022
ROE -93.2%
FY 2016: 0.0%FY 2017: -45.3%FY 2018: -44.4%FY 2019: 53.4%FY 2020: 55.5%FY 2021: 39.2%FY 2022: -93.2%
FY 2016 5y median 39.2% FY 2022
ROIC -78.3%
FY 2016: 0.0%FY 2017: -43.2%FY 2018: -44.6%FY 2019: -52.7%FY 2020: -88.7%FY 2021: -101.5%FY 2022: -78.3%
FY 2016 5y median -78.3% FY 2022
ROA -47.9%
FY 2016: 0.0%FY 2017: -40.7%FY 2018: -43.0%FY 2019: 56.1%FY 2020: -76.7%FY 2021: -84.4%FY 2022: -47.9%
FY 2016 5y median -47.9% FY 2022

Growth (YoY)

Revenue 824.4%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 824.4%
FY 2016 FY 2022
Operating Income -10.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -193.4%FY 2019: -65.5%FY 2020: -124.7%FY 2021: -15.9%FY 2022: -10.9%
FY 2016 FY 2022
EPS (diluted) 16.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -337.0%FY 2019: 11.9%FY 2020: -80.8%FY 2021: 3.7%FY 2022: 16.0%
FY 2016 FY 2022
Free Cash Flow 20.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -363.8%FY 2019: -59.3%FY 2020: -114.7%FY 2021: -24.4%FY 2022: 20.9%
FY 2016 FY 2022

Financial Health

Current Ratio 1.9×
FY 2016: 0.4×FY 2017: 17.5×FY 2018: 32.9×FY 2019: 22.4×FY 2020: 7.6×FY 2021: 4.4×FY 2022: 1.9×
FY 2016 5y median 7.6× FY 2022
Quick Ratio 1.9×
FY 2016: 0.4×FY 2017: 17.5×FY 2018: 32.9×FY 2019: 22.4×FY 2020: 7.6×FY 2021: 4.4×FY 2022: 1.9×
FY 2016 5y median 7.6× FY 2022
Debt / Equity 0.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -0.0×FY 2021: -0.0×FY 2022: 0.2×
FY 2016 5y median 0.0× FY 2022
Net Debt / EBITDA 0.2×
FY 2016: 0.0×FY 2017: 2.4×FY 2018: 2.2×FY 2019: 0.9×FY 2020: 1.0×FY 2021: 0.7×FY 2022: 0.2×
FY 2016 5y median 0.9× FY 2022
Interest Coverage -124×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -124×
FY 2016 5y median 0.0× FY 2022

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31